About PCR Reagent
The polymerase chain reaction, or PCR, is one of the advanced molecular techniques in molecular biology. Reagents used for PCR are known as PCR reagents such as Taq polymerase, buffers, dNTPs, kits, and Master Mixes, which are premixed, ready-to-use solutions. The application span of PCR and its reagents is enormous, encompassing numerous biomedical areas, forensics, gene therapy, food/beverage, and environmental testing. Additionally, the growth of the PCR reagent market is primarily driven by the increasing incidences of target diseases and genetic disorders coupled with continuous technological advancements in PCR technologies and reagents.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global PCR Reagent market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific, Inc. (United States), Promega Corporation (United States), Abbott Laboratories, Inc. (United States), LGC Group (United Kingdom), Asuragen, Inc. (United States), Takara Bio, Inc. (Japan), Bio-Rad Laboratories, Inc. (United States) and Siemens Healthcare GmbH (Siemens AG) (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Qiagen N.V. (Netherlands), Danaher Corporation (United States), Agilent Technologies (United States) and Roche Diagnostics (Switzerland).
Segmentation Overview
AMA Research has segmented the market of Global PCR Reagent market by Type (Primer, Enzyme, DNTP, Template and Buffer Solution), Application (Medical Care, Scientific Research and Others) and Region.
On the basis of geography, the market of PCR Reagent has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End users, the sub-segment i.e. Research Centers and Academic & Government Institutes will boost the PCR Reagent market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Real-time PCR will boost the PCR Reagent market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
PCR Reagent Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Rising Demand for Rapid, Accurate, and Cost Effective Diagnostic Tests in Health Care
- Increasing Usage in Food Safety Techniques
- Development in Pharmacogenomics and Emergence of Digital PCR Technology
- Owing to High Consumption of PCR Reagents & Consumables
|
Influencing Trends | - Increasing Demand for PCR machines and its reagents in Genetic and Molecular Testing
- The Emergence of Alternate Technologies like Next Generation Sequencing (NGS) along with Regulatory Interventions
|
Restraints | - High Cost of PCR Reagents is hampering the Market Growth
|
Road Blocks / Challenges | - Lack of Skilled labors for Handling PCR Techniques Market
- Accurate and Timely Result for RT-PCR faced by PCR Technology Market
|
Gaps & Opportunities | - Increasing Affinity for Automated High throughput and Robotic Equipment
- Rising Investment in R & D in Advanced Molecular Biology
|
Market Leaders and their expansionary development strategies
In January 2019, QIAGEN N.V. (Germany) announced the development of next-generation systems for dPCR in the life sciences industry. It is expected to launch new products in 2020.
In February 2019, Bio-Rad Laboratories (US) received US FDA approval for QxDx Auto DG droplet dPCR system and the QxDx BCR-ABL %IS Kit. and Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Key Target Audience
PCR Reagent Manufacturers, Potential Investors, Downstream Vendors, Industry Associations, Government and Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.